ACA
CELG

Aptus Capital Advisors’s Celgene Corp CELG Stock Holding History

Aptus Capital Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14,529
Closed -$1.44M – 596
2019
Q3 		$1.44M Sell
14,529
-2,243
-13% -$213K 0.08% 148
2019
Q2 		$1.55M Sell
16,772
-2,088
-11% -$198K 0.22% 83
2019
Q1 		$1.78M Sell
18,860
-1,000
-5% -$87.5K 0.3% 73
2018
Q4 		$1.27M Buy
+19,860
New +$1.47M 0.34% 56

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Aptus Capital Advisors's CELG Position: Q4 2019 in Review

Aptus Capital Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 14,529 shares — an estimated $1.44M sold.

Aptus Capital Advisors first reported a position in CELG in Q4 2018 and held it in 4 quarters. The position peaked at $1.78M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Aptus Capital Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Aptus Capital Advisors sold 14,529 Celgene Corp shares in Q4 2019, an estimated $1.44M.
  • Aptus Capital Advisors first reported a position in Celgene Corp in Q4 2018 and held it in 4 quarters.
  • Aptus Capital Advisors's Celgene Corp position peaked at $1.78M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Aptus Capital Advisors's 13F filing for Q4 2019, filed 10 Feb 2020.